Illumina Guilty of Infringing Five Affy Patents, Ordered to Pay $16.7M, Says it Will Appeal

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) A jury has found Illumina guilty of infringing five Affymetrix patents and has required it to pay Affy $16.7 million in royalties, according to a verdict filed today in a US District Court in Delaware.

Illumina plans to appeal. In a statement issued today, Illumina CEO Jay Flatley said that the verdict was made "without consideration of the validity and enforceability of any of the patents asserted by Affymetrix" and is therefore "preliminary."


For full article, follow this link.